Trials / Sponsors / Accent Therapeutics
Accent Therapeutics
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tu Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer | Phase 1 | 2025-03-21 |
| Terminated | First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumo Advanced Solid Tumors, Breast Cancer Recurrent, Colorectal Cancer Metastatic | Phase 1 | 2024-10-11 |